1. Home
  2. CORT vs PEGA Comparison

CORT vs PEGA Comparison

Compare CORT & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • PEGA
  • Stock Information
  • Founded
  • CORT 1998
  • PEGA 1983
  • Country
  • CORT United States
  • PEGA United States
  • Employees
  • CORT N/A
  • PEGA N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • PEGA EDP Services
  • Sector
  • CORT Health Care
  • PEGA Technology
  • Exchange
  • CORT Nasdaq
  • PEGA Nasdaq
  • Market Cap
  • CORT 7.6B
  • PEGA 9.2B
  • IPO Year
  • CORT N/A
  • PEGA 1996
  • Fundamental
  • Price
  • CORT $71.32
  • PEGA $58.04
  • Analyst Decision
  • CORT Strong Buy
  • PEGA Buy
  • Analyst Count
  • CORT 4
  • PEGA 11
  • Target Price
  • CORT $139.00
  • PEGA $60.45
  • AVG Volume (30 Days)
  • CORT 659.5K
  • PEGA 1.1M
  • Earning Date
  • CORT 10-29-2025
  • PEGA 10-22-2025
  • Dividend Yield
  • CORT N/A
  • PEGA 0.10%
  • EPS Growth
  • CORT N/A
  • PEGA 61.54
  • EPS
  • CORT 1.11
  • PEGA 1.18
  • Revenue
  • CORT $716,080,000.00
  • PEGA $1,676,025,000.00
  • Revenue This Year
  • CORT $30.62
  • PEGA $16.35
  • Revenue Next Year
  • CORT $37.68
  • PEGA $6.37
  • P/E Ratio
  • CORT $63.88
  • PEGA $49.23
  • Revenue Growth
  • CORT 25.71
  • PEGA 12.47
  • 52 Week Low
  • CORT $37.82
  • PEGA $29.84
  • 52 Week High
  • CORT $117.33
  • PEGA $60.96
  • Technical
  • Relative Strength Index (RSI)
  • CORT 51.04
  • PEGA 61.22
  • Support Level
  • CORT $67.32
  • PEGA $55.84
  • Resistance Level
  • CORT $74.79
  • PEGA $57.93
  • Average True Range (ATR)
  • CORT 2.43
  • PEGA 1.42
  • MACD
  • CORT 0.10
  • PEGA 0.51
  • Stochastic Oscillator
  • CORT 53.55
  • PEGA 80.50

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.

Share on Social Networks: